-
公开(公告)号:US20130053362A1
公开(公告)日:2013-02-28
申请号:US13552516
申请日:2012-07-18
申请人: Alfredo C. CASTRO , Catherine A. EVANS , Somarajannair JANARDANANNAIR , Andre LESCARBEAU , Tao LIU , Daniel A. SNYDER , Martin R. TREMBLAY , Pingda REN , Yi LIU , Liansheng LI , Katrina CHAN
发明人: Alfredo C. CASTRO , Catherine A. EVANS , Somarajannair JANARDANANNAIR , Andre LESCARBEAU , Tao LIU , Daniel A. SNYDER , Martin R. TREMBLAY , Pingda REN , Yi LIU , Liansheng LI , Katrina CHAN
IPC分类号: A61K31/506 , C07D401/12 , C07D471/04 , C07D403/12 , A61K31/517 , A61P37/00 , C07D417/14 , C07D413/14 , C07D405/14 , A61K31/5377 , A61P35/00 , A61P29/00 , C07D401/14 , C07D403/14
CPC分类号: C07D401/14 , A61K31/506 , A61K31/517 , A61K31/5377 , A61K45/06 , C07D401/12 , C07D403/12 , C07D403/14 , C07D405/14 , C07D411/14 , C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D495/04 , C07D513/04 , C12N9/1205 , C12Y207/01137 , Y02A50/414
摘要: Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including P13 kinase activity, are described herein.
摘要翻译: 本文描述了调节激酶活性(包括PI3激酶活性)的化合物和药物组合物,以及化合物,药物组合物和治疗与激酶活性(包括P13激酶活性)相关的疾病和病症的方法。
-
公开(公告)号:US20120149701A1
公开(公告)日:2012-06-14
申请号:US13403394
申请日:2012-02-23
申请人: Pingda REN , Yi LIU , Troy Edward WILSON , Liansheng LI , Katrina CHAN , Christian ROMMEL
发明人: Pingda REN , Yi LIU , Troy Edward WILSON , Liansheng LI , Katrina CHAN , Christian ROMMEL
IPC分类号: A61K31/5377 , A61K31/52 , A61P35/00 , A61P19/08 , A61P29/00 , A61P37/00 , A61P25/00 , A61P3/00 , A61P9/00 , A61P7/02 , A61P35/02 , A61P11/06 , A61P37/08 , A61P17/06 , A61P19/02 , A61P17/00 , A61P1/00 , C12N9/99
CPC分类号: A61K31/4725 , A61K31/131 , A61K31/196 , A61K31/506 , A61K31/52 , A61K31/5377 , A61K39/3955 , A61K39/39558 , A61K45/06 , A61N5/10 , A61N5/1007 , A61N2005/109 , C07D473/34 , C07D487/04 , Y02A50/401 , Y02A50/414 , Y02A50/465 , Y02P20/55
摘要: Chemical entities that modulate PI3 kinase activity, pharmaceutical compositions containing the chemical entities, and methods of using these chemical entities for treating diseases and conditions associated with P13 kinase activity are described herein.
摘要翻译: 本文描述了调节PI3激酶活性的化学实体,含有化学实体的药物组合物,以及使用这些化学实体治疗与P13激酶活性相关的疾病和病症的方法。
-